Hypertension is a complex disease process involving many pathophysiological changes. In this program project, the individual research topics focus on the theme that cytokines contribute to abnormal blood pressure regulation in angiotensin II-induced hypertension. The strategy of the group is to monitor many relevant variables during the development of hypertension with the goal of defining the complete sequence of events from the introduction of an intervention (angiotensin II or cage switch stress) to the resultant elevation in blood pressure. Among these variables are alterations in neural and endocrine factors, cellular events and molecular and gene characteristics. Five principal investigators from two administrative units have joined to study these changes. Animal models will include mice and rats (experimental hypertension and genetically modified). Among the specific variables measured will be the following: mRNA for specific proteins, enzyme activities, genetic associations, vascular reactivity, blood pressure, hormone levels, endothelium-derived products, cytokines, calcium, reactive oxygen species and arachidonic acid metabolites. Research strategies will utilize the professional expertise and equipment described in two of the core units (Core A, Animal and Core B, Biochemistry). Biostatistical support and scientific management will be coordinated through the Administrative Unit. From these integrated projects, a better understanding of the factors contributing to hypertension will emerge.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL074167-02
Application #
6889268
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Velletri, Paul A
Project Start
2004-05-01
Project End
2009-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
2
Fiscal Year
2005
Total Cost
$2,129,352
Indirect Cost
Name
Georgia Health Sciences University
Department
Physical Medicine & Rehab
Type
Schools of Medicine
DUNS #
966668691
City
Augusta
State
GA
Country
United States
Zip Code
30912
Guan, Z; Wang, F; Cui, X et al. (2018) Mechanisms of sphingosine-1-phosphate-mediated vasoconstriction of rat afferent arterioles. Acta Physiol (Oxf) 222:
Guan, Zhengrong; Singletary, Sean T; Cha, Haword et al. (2016) Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive rats. Am J Physiol Renal Physiol 310:F456-65
Guan, Zhengrong; Singletary, Sean T; Cook, Anthony K et al. (2014) Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature. J Am Soc Nephrol 25:1774-85
Guan, Zhengrong; Fellner, Robert C; Van Beusecum, Justin et al. (2014) P2 receptors in renal autoregulation. Curr Vasc Pharmacol 12:818-28
Speed, Joshua S; Pollock, David M (2013) Endothelin, kidney disease, and hypertension. Hypertension 61:1142-5
Lobato, Nubia S; Filgueira, Fernando P; Prakash, Roshini et al. (2013) Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats. PLoS One 8:e63449
Guan, Zhengrong; Giddens, Matthew I; Osmond, David A et al. (2013) Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats. Am J Physiol Renal Physiol 304:F801-7
Lima, Victor V; Giachini, Fernanda R; Carneiro, Fernando S et al. (2011) O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovasc Res 89:614-22
Choi, Hyehun; Tostes, Rita C; Webb, R Clinton (2011) S-nitrosylation Inhibits protein kinase C-mediated contraction in mouse aorta. J Cardiovasc Pharmacol 57:65-71
Inscho, Edward W; Cook, Anthony K; Clarke, Andrea et al. (2011) P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet. Hypertension 57:780-7

Showing the most recent 10 out of 125 publications